What does Pharmacie HOMEOPLANT do?

Pharmacie HOMEOPLANT is a pharmacy in Namur. Private Limited, started on 10 July 2013, 1 establishment.

What is the address of Pharmacie HOMEOPLANT?

The registered office of Pharmacie HOMEOPLANT is located at Rue Alfred Denis(FW) 1, 5020 Namur.

Is Pharmacie HOMEOPLANT still active?

Yes. According to the CBE (30 September 2026) Pharmacie HOMEOPLANT is active, legal situation “Normale toestand”, started on 10 July 2013.

Is Pharmacie HOMEOPLANT registered on Peppol?

Yes, Pharmacie HOMEOPLANT is registered on the Peppol network with ID 0208:0536599248.

What is the enterprise number of Pharmacie HOMEOPLANT?

The enterprise number of Pharmacie HOMEOPLANT is BE0536599248.

When was Pharmacie HOMEOPLANT founded?

Pharmacie HOMEOPLANT was founded on 10 July 2013.

Who are the directors of Pharmacie HOMEOPLANT?

According to the 2025 annual accounts, the directors of Pharmacie HOMEOPLANT are: Alexandre MANIRAMBONA.

Is Pharmacie HOMEOPLANT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 July 2013; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmacie HOMEOPLANT make in 2025?

Pharmacie HOMEOPLANT posted a profit after taxes of € 79,950 in financial year 2025.

What is the revenue of Pharmacie HOMEOPLANT?

As a small company, Pharmacie HOMEOPLANT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 116,333.

Pharmacie HOMEOPLANT (Private Limited) - Namur

Dossier Pharmacie HOMEOPLANT, printed on 30 September 2026 from databakkes.be/en/0536599248/pharmacie-homeoplant. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie HOMEOPLANT from Namur, company number BE0536599248, closed financial year 2025 with a result of € 79,950 after tax. For that financial year Pharmacie HOMEOPLANT recorded a gross margin of € 116,333 and equity of € 20,460. Compared with financial year 2024, the result moved from € 80,434 to € 79,950. The company is profitable. The buffer shrank hard: equity is 75 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.

What it is worth Shrank hard

€ 20,460

▼ 75% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 79,950

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 151,207

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 140,397 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 35,731

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,854

▼ 27% vs 2024

€ 12,734 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 79,151

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,054

▲ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 114,611 Gross margin 2022: € 114,611 First fiscal year in the series	€ 95,933 Gross margin 2023: € 95,933 ▼ 16% vs 2022 (€ 114,611) Unfavourable step	€ 114,059 Gross margin 2024: € 114,059 ▲ 19% vs 2023 (€ 95,933) Favourable step	€ 116,333 Gross margin 2025: € 116,333 ▲ 2% vs 2024 (€ 114,059) Favourable step	▲ 2%
Profit after taxes	€ 60,929 Profit after taxes 2022: € 60,929 First fiscal year in the series	€ 46,233 Profit after taxes 2023: € 46,233 ▼ 24% vs 2022 (€ 60,929) Unfavourable step	€ 80,434 Profit after taxes 2024: € 80,434 ▲ 74% vs 2023 (€ 46,233) Favourable step	€ 79,950 Profit after taxes 2025: € 79,950 ▼ 1% vs 2024 (€ 80,434) Unfavourable step	▼ 1%
Equity	€ 159,840 Equity 2022: € 159,840 First fiscal year in the series	€ 96,073 Equity 2023: € 96,073 ▼ 40% vs 2022 (€ 159,840) Unfavourable step	€ 80,907 Equity 2024: € 80,907 ▼ 16% vs 2023 (€ 96,073) Unfavourable step	€ 20,460 Equity 2025: € 20,460 ▼ 75% vs 2024 (€ 80,907) Unfavourable step	▼ 75%
Total debts	€ 117,404 Total debts 2022: € 117,404 First fiscal year in the series	€ 218,109 Total debts 2023: € 218,109 ▲ 86% vs 2022 (€ 117,404) Unfavourable step	€ 250,981 Total debts 2024: € 250,981 ▲ 15% vs 2023 (€ 218,109) Unfavourable step	€ 278,823 Total debts 2025: € 278,823 ▲ 11% vs 2024 (€ 250,981) Unfavourable step	▲ 11%
Cash	€ 153,599 Cash 2022: € 153,599 First fiscal year in the series	€ 180,472 Cash 2023: € 180,472 ▲ 17% vs 2022 (€ 153,599) Favourable step	€ 183,275 Cash 2024: € 183,275 ▲ 2% vs 2023 (€ 180,472) Favourable step	€ 151,207 Cash 2025: € 151,207 ▼ 17% vs 2024 (€ 183,275) Unfavourable step	▼ 17%
Retained profit	€ 153,640 Retained profit 2022: € 153,640 First fiscal year in the series	€ 89,873 Retained profit 2023: € 89,873 ▼ 42% vs 2022 (€ 153,640) Unfavourable step	€ 62,307 Retained profit 2024: € 62,307 ▼ 31% vs 2023 (€ 89,873) Unfavourable step	€ 1,860 Retained profit 2025: € 1,860 ▼ 97% vs 2024 (€ 62,307) Unfavourable step	▼ 97%
Dividend	€ 500 Dividend 2022: € 500 First fiscal year in the series	€ 110,000 Dividend 2023: € 110,000 ▲ € 109,500 vs 2022 (€ 500) Unchanged	€ 108,000 Dividend 2024: € 108,000 ▼ 2% vs 2023 (€ 110,000) Unchanged	€ 140,397 Dividend 2025: € 140,397 ▲ 30% vs 2024 (€ 108,000) Unchanged	▲ 30%
Bank debt	€ 35,653 Bank debt 2022: € 35,653 First fiscal year in the series	€ 11,574 Bank debt 2023: € 11,574 ▼ 68% vs 2022 (€ 35,653) Favourable step	€ 46,140 Bank debt 2024: € 46,140 ▲ 299% vs 2023 (€ 11,574) Unfavourable step	€ 33,854 Bank debt 2025: € 33,854 ▼ 27% vs 2024 (€ 46,140) Favourable step	▼ 27%
Balance sheet total	€ 277,243 Balance sheet total 2022: € 277,243 First fiscal year in the series	€ 314,182 Balance sheet total 2023: € 314,182 ▲ 13% vs 2022 (€ 277,243) Unchanged	€ 331,888 Balance sheet total 2024: € 331,888 ▲ 6% vs 2023 (€ 314,182) Unchanged	€ 299,283 Balance sheet total 2025: € 299,283 ▼ 10% vs 2024 (€ 331,888) Unchanged	▼ 10%

Key figures of Pharmacie HOMEOPLANT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Pharmacie HOMEOPLANT?

What happened at Pharmacie HOMEOPLANT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 2, 2026 New annual accounts for financial year 2025: profit of € 79,950 (▼ 1% vs 2024). filed late Source: NBB ↗
Jul 10, 2013 New establishment in Charleroi. KBO
2013 Alexandre MANIRAMBONA became a director. NBB
Jul 10, 2013 Start of the company according to the CBE. KBO

In short

From € 60,929 profit in 2022 to € 79,950 profit in 2025.

Paid € 78,627 in corporate taxes since 2022.

Best year ever: 2024, with € 80,434 profit.

Paid out € 358,897 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Pharmacie HOMEOPLANT? We notify you, reason included.

Follow Pharmacie HOMEOPLANT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Alexandre MANIRAMBONA

Pharmacie HOMEOPLANT

Behind Pharmacie HOMEOPLANT is Alexandre MANIRAMBONA.

See the full network in the app

Directors

According to the 2025 annual accounts

Alexandre MANIRAMBONA

Manager

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Alfred Denis(FW) 1

5020 Namur

2.220.573.785

Rue des Bateliers 53

6030 Charleroi

Active since 10 July 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0536.599.248

VAT number

BE 0536.599.248

Registered office

Rue Alfred Denis(FW) 1, 5020 Namur

Names & denominations

Pharmacie HOMEOPLANT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 July 2013

Peppol

Active · Active since 26 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie HOMEOPLANT

Financials

What happened to Pharmacie HOMEOPLANT?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions